EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the Role of Cav1.2 VGCCs and PDGF-BB/PDGFRβ Signaling in Diabetes-Associated Wound Healing Impairment

Lutfi Nurdian Asnindari, Denny Agustiningsih, Khudazi Aulawi

Trends in Sciences · 15.07.2026 · 23 (12) · 14195

DOI: 10.48048/tis.2026.14195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 15.07.2026. Verfasst von Lutfi Nurdian Asnindari und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcers (DFUs) are a significant complication of diabetes with high recurrence and prolonged healing. To promote the healing of DFUs, relevant molecular signaling pathways must be modulated. Therefore, this study examines the role of Cav1.2 voltage-gated calcium channel (VGCC)-mediated platelet-derived growth factor (PDGF)-BB/platelet-derived growth factor receptor (PDGFR) β-extracellular signal-regulated kinase (ERK)1/2 signaling in impaired wound healing in diabetes. Immunohistochemistry was used to evaluate Cav1.2 VGCC, PDGFRβ, and collagen I; enzyme-linked immunosorbent assay (ELISA) was used to quantify PDGF-BB, ERK1/2, and α-smooth muscle actin (SMA); and hematoxylin and eosin staining was used to assess re-epithelialization. Twelve Wistar rats were allocated to normal and diabetic groups, with diabetes induced by streptozotocin (STZ) and nicotinamide (NA) administration. Four full-thickness skin wounds were generated on the dorsum of each rat using a punch biopsy. Wounds were treated every 2 days for a total of 6 days with standard treatments. Skin samples were collected 7 days after the initial injury. There was no correlation between Cav1.2 VGCCs and PDGFRβ (r = ‒0.5885, p = 0.233), as well as between PDGFRβ and ERK1/2 (r = 0.3879, p = 0.447). In contrast, a significant correlation was observed between PDGF-BB and α-SMA (r = 0.8644, p = 0.026). Furthermore, Cav1.2 VGCC expression, PDGF-BB levels, and ERK1/2 levels did not differ significantly (p > 0.05). However, PDGFRβ expression, level of α-SMA, collagen I expression, and re-epithelialization were significantly reduced in diabetic wound rats compared with those in normal rats (p < 0.05). Altogether, the findings support the involvement of PDGF-BB/PDGFRβ signaling in impaired diabetic wound healing. In contrast, no significant association was detected between Cav1.2 VGCCs and disrupted wound healing in diabetic rats. These findings underscore the need for further investigation to clarify the functions of these pathways and to identify potential therapeutic interventions. HIGHLIGHTS PDGF-BB/PDGFRβ signaling critically modulates diabetic wound healing impairment. 2 VGCCs do not significantly contribute to diabetes-induced disruption in wound healing. Diabetic rat wounds showed reduced PDGFRβ, α‑SMA, collagen I, and re‑epithelialization. GRAPHICAL ABSTRACT

Zitieren

APA

Asnindari, L. N., Agustiningsih, D., & Aulawi, K. (2026). Exploring the Role of Cav1.2 VGCCs and PDGF-BB/PDGFRβ Signaling in Diabetes-Associated Wound Healing Impairment. Trends in Sciences, 23(12), 14195. https://doi.org/10.48048/tis.2026.14195

Vancouver

Asnindari LN, Agustiningsih D, Aulawi K. Exploring the Role of Cav1.2 VGCCs and PDGF-BB/PDGFRβ Signaling in Diabetes-Associated Wound Healing Impairment. Trends in Sciences. 2026;23(12):14195. doi:10.48048/tis.2026.14195

BibTeX
@article{Asnindari2026,
  author = {Asnindari, Lutfi Nurdian and Agustiningsih, Denny and Aulawi, Khudazi},
  title = {Exploring the Role of Cav1.2 VGCCs and PDGF-BB/PDGFRβ Signaling in Diabetes-Associated Wound Healing Impairment},
  journal = {Trends in Sciences},
  year = {2026},
  volume = {23},
  number = {12},
  pages = {14195},
  doi = {10.48048/tis.2026.14195}
}
Kostenlos starten →